David Kent, MD, Honored by Election to the Association of American Physicians
David Kent, MD, professor of medicine and neurology at Tufts University School of Medicine, has been elected to the Association of American Physicians (AAP), a prestigious medical society that recognizes the nation’s leading physician-scientists. Election to the AAP is limited to just 70 physicians each year and honors individuals with outstanding contributions to basic and translational biomedical research.
Founded in 1885, the AAP is among the most respected medical honor societies in the United States. Its members represent a select community of physician‑scientists whose original and influential research has fundamentally advanced biomedical science and strengthened both clinical and translational medicine.
Dr. Kent is director of the Predictive Analytics and Comparative Effectiveness (PACE) Center within the Institute for Clinical Research and Health Policy Studies (ICRHPS) at Tufts Medical Center and program director of the Clinical and Translational Science (CTS) Programs at the Tufts Graduate School of Biomedical Sciences.
A clinician-methodologist, his research focuses on predictive modeling, individual patient data meta-analysis, and comparative effectiveness research aimed at improving how evidence is applied to individual patients.
“Dr. Kent’s pioneering research on heterogeneity of treatment effects has advanced individualized medicine, providing a rigorous framework for assessing who benefits most—or least—from interventions,” wrote Harry P. Selker, MD, MSPH, dean of the Clinical and Translational Science Institute at Tufts University and executive director of the ICRHPS, in his nomination letter to the AAP.
Dr. Kent has also developed influential tools widely used in stroke prevention and clinical research, including the Risk of Paradoxical Embolism (RoPE) Score and the PASCAL Classification, both incorporated into major clinical guidelines. His PATH Statement, published in 2021, has also helped guide new analyses of clinical trial data to better evaluate how treatment effects vary across patient populations.
Currently, Dr. Kent leads research applying artificial intelligence to identify patients with covert cerebrovascular disease—an underdiagnosed condition associated with increased risk of stroke and dementia—and develop new approaches to prevention. He is also creating frameworks for evaluating and monitoring clinical prediction models as they are integrated into electronic health records, supporting the responsible use of emerging AI‑driven tools.
As Dr. Selker noted, “These contributions have reshaped predictive analytics and comparative effectiveness research, establishing new standards for personalized treatment across cardiovascular and neurological medicine.”
In addition to his scientific leadership, Dr. Kent has made significant contributions to training the next generation of physician-scientists. As program director of CTS Programs, he helps equip emerging clinicians and researchers with the rigorous methodological training needed to translate discoveries into improved patient care. He has mentored more than 60 trainees through these efforts, strengthening both the science and the workforce advancing personalized medicine. The CTS Programs include PhD, MS, and Certificate options designed to meet learners at every level and interest.
Dr. Kent’s election to the Association of American Physicians recognizes a career dedicated to improving how clinical evidence is generated and applied to patient care.